臺大學術典藏 |
2022-05-13T08:05:10Z |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Fang C.-T.; Shau W.-Y.; Hsueh P.-R.; Chen Y.-C.; JANN-TAY WANG; Hung C.-C.; Huang L.Y.L.; Chang S.-C. |
臺大學術典藏 |
2021-12-01T06:03:01Z |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Fang C.-T.; Shau W.-Y.; Hsueh P.-R.; YEE-CHUN CHEN; Wang J.-T.; Hung C.-C.; Huang L.Y.L.; Chang S.-C. |
臺大學術典藏 |
2021-12-01T02:30:14Z |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Fang C.-T.; Shau W.-Y.; Hsueh P.-R.; Chen Y.-C.; Wang J.-T.; CHIEN-CHING HUNG; Huang L.Y.L.; Chang S.-C. |
臺大學術典藏 |
2021-05-06T01:52:46Z |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Fang C.-T.; Shau W.-Y.; Hsueh P.-R.; YEE-CHUN CHEN; Wang J.-T.; Hung C.-C.; Huang L.Y.L.; Chang S.-C. |
臺大學術典藏 |
2021-04-20T03:46:22Z |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Chi-Tai Fang;Shau W.-Y.;Hsueh P.-R.;Chen Y.-C.;Wang J.-T.;Hung C.-C.;Huang L.Y.L.;Chang S.-C.; CHI-TAI FANG; Shau W.-Y.; Hsueh P.-R.; Chen Y.-C.; Wang J.-T.; Hung C.-C.; Huang L.Y.L.; Chang S.-C. |
臺大學術典藏 |
2021-04-20T03:46:21Z |
Comparison of meeting abstracts and subsequent articles [10]
|
Chi-Tai Fang;Huang L.Y.L.; CHI-TAI FANG; Huang L.Y.L. |
臺大學術典藏 |
2021-04-20T03:46:20Z |
Cost-effectiveness of highly active antiretroviral therapy for HIV infection in Taiwan
|
Chi-Tai Fang;Chang Y.-Y.;Hsu H.-M.;Twu S.-J.;Chen K.-T.;Chen M.-Y.;Huang L.Y.L.;Hwang J.-S.;Wang J.-D.; CHI-TAI FANG; Chang Y.-Y.; Hsu H.-M.; Twu S.-J.; Chen K.-T.; Chen M.-Y.; Huang L.Y.L.; Hwang J.-S.; Wang J.-D. |
臺大學術典藏 |
2021-04-20T03:46:19Z |
Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy
|
Chi-Tai Fang;Chang Y.Y.;Hsu H.M.;Twu S.J.;Chen K.T.;Lin C.C.;Huang L.Y.L.;Chen M.Y.;Hwang J.S.;Wang J.D.;Chuang C.Y.; CHI-TAI FANG; Chang Y.Y.; Hsu H.M.; Twu S.J.; Chen K.T.; Lin C.C.; Huang L.Y.L.; Chen M.Y.; Hwang J.S.; Wang J.D.; Chuang C.Y. |
臺大學術典藏 |
2020-12-18T08:39:30Z |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Chen Y.-C.; PO-REN HSUEH; Shau W.-Y.; Fang C.-T.; Fang C.-T.;Shau W.-Y.;Po-Ren Hsueh;Chen Y.-C.;Wang J.-T.;Hung C.-C.;Huang L.Y.L.;Chang S.-C.; Wang J.-T.; Hung C.-C.; Huang L.Y.L.; Chang S.-C. |
臺大學術典藏 |
2020-09-30T03:23:08Z |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Wang J.-T.; CHIEN-CHING HUNG; Huang L.Y.L.; Chang S.-C.; Chen Y.-C.; Hsueh P.-R.; Shau W.-Y.; Fang C.-T.; Fang C.-T.;Shau W.-Y.;Hsueh P.-R.;Chen Y.-C.;Wang J.-T.;Chien-Ching Hung;Huang L.Y.L.;Chang S.-C. |
國立成功大學 |
2007-02 |
Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy
|
Fang, C. T.; Chang, Y. Y.; Hsu, H. M.; Twu, S. J.; Chen, Kow-Tong; Lin, C. C.; Huang, L. Y. L.; Chen, M. Y.; Hwang, J. S.; Wang, J. D.; Chuang, C. Y. |
臺大學術典藏 |
2006 |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Chang S.-C.; Huang L.Y.L.; Wang J.-T.; Hung C.-C.; Chen Y.-C.; PO-REN HSUEH; Chang S.-C.;Huang L.Y.L.;Hung C.-C.;Wang J.-T.;Chen Y.-C.;PO-REN HSUEH;Shau W.-Y.;Fang C.-T.; Fang C.-T.; Shau W.-Y. |
臺大學術典藏 |
2006 |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Fang C.-T.;Shau W.-Y.;Hsueh P.-R.;Yee-Chun Chen;Wang J.-T.;Hung C.-C.;Huang L.Y.L.;Chang S.-C.; Fang C.-T.; Shau W.-Y.; Hsueh P.-R.; YEE-CHUN CHEN; Wang J.-T.; Hung C.-C.; Huang L.Y.L.; Chang S.-C. |
臺大學術典藏 |
2006 |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Chang S.-C.; Huang L.Y.L.; Hung C.-C.; JANN-TAY WANG; Chen Y.-C.; Fang C.-T.;Shau W.-Y.;Hsueh P.-R.;Chen Y.-C.;Jann-Tay Wang;Hung C.-C.;Huang L.Y.L.;Chang S.-C.; Fang C.-T.; Shau W.-Y.; Hsueh P.-R. |
臺大學術典藏 |
2006 |
Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome
|
Fang C.-T.;Shau W.-Y.;Hsueh P.-R.;Chen Y.-C.;Wang J.-T.;Hung C.-C.;Huang L.Y.L.;Shan-Chwen Chang; Fang C.-T.; Shau W.-Y.; Hsueh P.-R.; Chen Y.-C.; Wang J.-T.; Hung C.-C.; Huang L.Y.L.; SHAN-CHWEN CHANG |